Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Codiak BioSciences, Inc. CDAK

Full chart Compare
Set alert

Price alert · CDAK

All alert types
0.06 +0.06

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-4.37 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -5.8×
FY 2018: -3.6×FY 2019: -2.0×FY 2020: -6.3×FY 2021: -5.8×
FY 2018 5y median -4.7× FY 2021
P/S 10.6×
FY 2018: 0.0×FY 2019: 410×FY 2020: 193×FY 2021: 10.6×
FY 2018 5y median 102× FY 2021
P/B 4.5×
FY 2018: 1.7×FY 2019: 7.3×FY 2020: 38.6×FY 2021: 4.5×
FY 2018 5y median 5.9× FY 2021
P/FCF -3.1×
FY 2018: -4.1×FY 2019: -13.1×FY 2020: -6.7×FY 2021: -3.1×
FY 2018 5y median -5.4× FY 2021
EV/EBITDA -8.2×
FY 2018: -3.3×FY 2019: -2.1×FY 2020: -6.4×FY 2021: -8.2×
FY 2018 5y median -4.8× FY 2021
EV/Sales 10.0×
FY 2018: 0.0×FY 2019: 408×FY 2020: 184×FY 2021: 10.0×
FY 2018 5y median 97.0× FY 2021
FCF Yield -31.9%
FY 2018: -24.5%FY 2019: -7.7%FY 2020: -15.0%FY 2021: -31.9%
FY 2018 5y median -19.7% FY 2021

Profitability

Gross Margin 100.0%
FY 2018: 0.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%
FY 2018 5y median 100.0% FY 2021
Operating Margin -303.2%
FY 2018: 0.0%FY 2019: -20657.7%FY 2020: -3119.0%FY 2021: -303.2%
FY 2018 5y median -1711.1% FY 2021
Net Margin -181.5%
FY 2018: 0.0%FY 2019: -20425.8%FY 2020: -3050.8%FY 2021: -181.5%
FY 2018 5y median -1616.2% FY 2021
ROE -77.8%
FY 2018: -48.4%FY 2019: -361.0%FY 2020: -610.5%FY 2021: -77.8%
FY 2018 5y median -219.4% FY 2021
ROIC -47.3%
FY 2018: -50.1%FY 2019: -83.3%FY 2020: -65.3%FY 2021: -47.3%
FY 2018 5y median -57.7% FY 2021
ROA -24.3%
FY 2018: -45.6%FY 2019: -68.3%FY 2020: -58.8%FY 2021: -24.3%
FY 2018 5y median -52.2% FY 2021

Growth (YoY)

Revenue 686.8%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 651.3%FY 2021: 686.8%
FY 2018 FY 2021
Operating Income 23.5%
FY 2018: 0.0%FY 2019: -72.6%FY 2020: -13.4%FY 2021: 23.5%
FY 2018 FY 2021
EPS (diluted) 62.6%
FY 2018: 0.0%FY 2019: -77.4%FY 2020: 15.3%FY 2021: 62.6%
FY 2018 FY 2021
Free Cash Flow 8.3%
FY 2018: 0.0%FY 2019: 68.7%FY 2020: -593.1%FY 2021: 8.3%
FY 2018 FY 2021

Financial Health

Current Ratio 3.3×
FY 2018: 18.6×FY 2019: 4.8×FY 2020: 5.3×FY 2021: 3.3×
FY 2018 5y median 5.0× FY 2021
Quick Ratio 3.3×
FY 2018: 18.6×FY 2019: 4.7×FY 2020: 5.3×FY 2021: 3.3×
FY 2018 5y median 5.0× FY 2021
Debt / Equity 1.2×
FY 2018: 0.0×FY 2019: 0.4×FY 2020: 4.3×FY 2021: 1.2×
FY 2018 5y median 0.8× FY 2021
Net Debt / EBITDA 0.5×
FY 2018: 0.4×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.5×
FY 2018 5y median 0.4× FY 2021
Interest Coverage -25.8×
FY 2018: 0.0×FY 2019: -267×FY 2020: -47.7×FY 2021: -25.8×
FY 2018 5y median -36.7× FY 2021

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31